Giant Biogene Holding Co Ltd (2367)

Currency in HKD
60.50
+0.50(+0.83%)
Closed·
2367 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
2367 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
58.6560.80
52 wk Range
35.0087.10
Key Statistics
Bid/Ask
60.50 / 60.55
Prev. Close
60
Open
60.6
Day's Range
58.65-60.8
52 wk Range
35-87.1
Volume
11.16M
Average Volume (3m)
13.32M
1-Year Change
47.92%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2367 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
78.38
Upside
+29.56%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Giant Biogene Holding Co Ltd Company Profile

Giant Biogene Holding Co., Ltd., an investment holding company, designs, develops, manufactures, and sells skin treatment products with recombinant collagen in the People’s Republic of China. It also develops and manufactures rare ginsenosides technology-based functional food products; and offers medical devices. The company provides its functional skincare products, medical dressings, and functional food products primarily under the Comfy, Collgene, Ke Yu, and SKIGIN brands. Giant Biogene Holding Co., Ltd. was founded in 2000 and is headquartered in Xi'an, the People’s Republic of China.

Compare 2367 to Peers and Sector

Metrics to compare
2367
Peers
Sector
Relationship
P/E Ratio
28.4x34.6x12.2x
PEG Ratio
0.72−0.650.03
Price/Book
8.2x2.3x1.5x
Price / LTM Sales
10.6x3.2x0.9x
Upside (Analyst Target)
30.6%11.6%17.5%
Fair Value Upside
Unlock14.3%10.6%Unlock

Analyst Ratings

21 Buy
0 Hold
0 Sell
Ratings:
21 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 78.38
(+29.56% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.10%
Dividend Yield
2.16%
Annualised payout
1.31
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 28, 2025
EPS / Forecast
1.09 / --
Revenue / Forecast
3.00B / --
EPS Revisions
Last 90 days

2367 Income Statement

People Also Watch

22.10
FAGRO
+1.84%
95.400
GBFG
+0.26%
2,965.5
6361
+4.29%
45.76
SDZ
+1.85%

FAQ

What Is the Giant Biogene Holding (2367) Stock Price Today?

The Giant Biogene Holding stock price today is 60.50

What Stock Exchange Does Giant Biogene Holding Trade On?

Giant Biogene Holding is listed and trades on the Hong Kong Stock Exchange stock exchange.

What Is the Stock Symbol for Giant Biogene Holding?

The stock symbol for Giant Biogene Holding is "2367."

Does Giant Biogene Holding Pay Dividends? What’s The Current Dividend Yield?

The Giant Biogene Holding dividend yield is 2.16%.

What Is the Giant Biogene Holding Market Cap?

As of today, Giant Biogene Holding market cap is 64.05B.

What Is Giant Biogene Holding's Earnings Per Share (TTM)?

The Giant Biogene Holding EPS (TTM) is 2.10.

From a Technical Analysis Perspective, Is 2367 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Giant Biogene Holding Stock Split?

Giant Biogene Holding has split 0 times.

How Many Employees Does Giant Biogene Holding Have?

Giant Biogene Holding has 1758 employees.

What is the current trading status of Giant Biogene Holding (2367)?

As of 19 July 2025, Giant Biogene Holding (2367) is trading at a price of 60.50, with a previous close of 60.00. The stock has fluctuated within a day range of 58.65 to 60.80, while its 52-week range spans from 35.00 to 87.10.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.